Author: Lynne Taylor

Starting in 2011, the global market for branded atypical antipsychotic drugs will experience significant erosion as a number of leading treatments begin to lose patent exclusivity and, as a result, the bipolar disorder drug market will have lost more than $1 billion in value by 2018, according to a new report.

The NHS has “no idea” how many patients are dying from 80% of healthcare-associated infections in hospitals because the Department of Health is refusing to introduce mandatory surveillance, say MPs.

US drugmakers say they are “disappointed but not surprised” that the House of Representatives has voted in favour of its health care reform legislation.

European drugmakers say they are willing to allow information on their medicines to undergo an independent vetting procedure before being made available to the public.

An advertisement which stunned cinema-goers earlier this year, by showing a man coughing up a dead rat after having taken a counterfeit drug, was shown for the first time on UK television last night.